Trial intelligence / Profile preview

Montelukast as Add-on Treatment for Acute Severe Asthma

NCT01011452Phase 4Completed

Sponsor
University of East Anglia
Start
May 2001
Primary completion
Aug 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in asthma comparing Montelukast with Placebo (2 arms). Primary endpoint: Difference in peak flow between active and placebo limbs at 24 hours. Started May 2001; status: completed.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01011452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01011452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call